Metabolic · 6 min read
The GLP-1 Landscape, Explained
What the incretin class is, how the molecules differ, and what the published research does — and doesn't — say yet.
Few areas of metabolic research have moved as fast as the incretin field. The names — semaglutide, tirzepatide, retatrutide — get used interchangeably in casual conversation, but they describe meaningfully different molecules. Here's the plain-language map.
What 'incretin' means
Incretins are gut-derived signaling hormones the body releases in response to food. The two most studied are GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). They act on receptors involved in glucose handling and satiety signaling. The research compounds in this class are engineered analogs designed to engage one or more of these receptors with greater stability than the natural hormones.
Single, dual, and triple agonism
The simplest framing is by how many receptors a molecule targets. Semaglutide is a GLP-1 receptor agonist — a single-target molecule. Tirzepatide is a dual agonist, engaging both GLP-1 and GIP receptors. Retatrutide goes a step further as a triple agonist (sometimes written 'GGG'), adding the glucagon receptor to the GLP-1 and GIP pair. Cagrilintide sits in an adjacent family as an amylin analog, which is why it's often studied alongside the others rather than as a direct substitute.
Why the differences matter to researchers
More targets is not automatically 'better' — it's different. Each added receptor changes the pharmacology a study has to account for: dosing ranges, titration schedules, and which physiological pathways are engaged. That's why the literature treats these as distinct tools rather than stronger versions of the same thing.
What the research does not say yet
Retatrutide, for example, remains under active clinical investigation and has no settled long-term profile in the public record. Across the class, comparative long-term data is still maturing. Anyone designing research here should read the primary literature directly rather than rely on summaries — including this one.
This is general education about published research, not medical advice. All compounds referenced are for research use only.